Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Axonics Inc
(NQ:
AXNX
)
67.67
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Axonics Inc
< Previous
1
2
3
4
Next >
Analyst Ratings for Axonics
May 02, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
April 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023
March 24, 2023
Via
Benzinga
Axonics Modulation Tech Earnings Preview
February 28, 2023
Via
Benzinga
Analyst Ratings for Axonics
January 06, 2023
Via
Benzinga
2 Fast-Growing Healthcare Stocks to Buy and Hold
December 02, 2022
The innovative companies have made great gains in a short period of time.
Via
The Motley Fool
Axonics Posts Smaller Than Expected Quarterly Loss, Raises Guidance
November 01, 2022
Via
Benzinga
Analyst Ratings for Axonics
October 21, 2022
Axonics (NASDAQ:AXNX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Earnings Scheduled For May 1, 2023
May 01, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
Via
Benzinga
Axonics Earnings Preview
April 28, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
Why Axonics Shares Are Trading Higher Today?
January 11, 2023
Axonics, Inc. (NASDAQ: AXNX) shares are trading higher after the company reported preliminary fourth-quarter and full-year 2022 total net revenue results above estimates. The company also issued FY23...
Via
Benzinga
Earnings Scheduled For October 31, 2022
October 31, 2022
Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.46 billion.
Via
Benzinga
Axonics Risk/Reward Ratio Is Less Favorable, Analyst Says While Downgrading Stock
October 10, 2022
Needham downgraded Axonics Inc (NASDAQ: AXNX) from Buy to Hold.
Via
Benzinga
Where Axonics Stands With Analysts
October 05, 2022
Within the last quarter, Axonics (NASDAQ:AXNX) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
October 21, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
Upgrades
Via
Benzinga
What 9 Analyst Ratings Have To Say About Axonics
August 02, 2022
Within the last quarter, Axonics (NASDAQ:AXNX) has observed the following analyst ratings:
Via
Benzinga
Analyst Ratings for Axonics
May 06, 2022
Within the last quarter, Axonics (NASDAQ:AXNX) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
Upgrades
Via
Benzinga
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
October 05, 2022
Biotech isn't the only place to make money in health care this year.
Via
Investor's Business Daily
Piper Sandler Maintains Overweight Rating for Axonics: Here's What You Need To Know
October 05, 2022
Piper Sandler has decided to maintain its Overweight rating of Axonics (NASDAQ:AXNX) and raise its price target from $82.00 to $84.00. Shares of Axonics are trading down 1.5% over the last 24 hours, at...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 02, 2022
Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is...
Via
Benzinga
Neuromodulation Focused Company Axonics Gets 28% Price Target Bump By This Analyst On Solid Q2 Performance
August 02, 2022
Via
Benzinga
Morgan Stanley Maintains Overweight Rating for Axonics: Here's What You Need To Know
August 02, 2022
Morgan Stanley has decided to maintain its Overweight rating of Axonics (NASDAQ:AXNX) and raise its price target from $73.00 to $80.00. Shares of Axonics are trading up 5.7% over the last 24 hours, at...
Via
Benzinga
Recap: Axonics Q2 Earnings
August 01, 2022
Axonics (NASDAQ:AXNX) reported its Q2 earnings results on Monday, August 1, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Axonics beat estimated earnings by...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 05, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 18, 2022
Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million.
Via
Benzinga
Earnings Scheduled For August 1, 2022
August 01, 2022
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
April 06, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.